Antioxidant Alternatives in the Treatment of Amyotrophic Lateral Sclerosis: A Comprehensive Review

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that produces a selective loss of the motor neurons of the spinal cord, brain stem and motor cortex. Oxidative stress (OS) associated with mitochondrial dysfunction and the deterioration of the electron transport chain has been shown...

Full description

Bibliographic Details
Authors: Sandra Carrera, Julia, Moreno Sancho, María de la Luz, Barrios Pitarque, Carlos, de la Rubia Ortí, José Enrique, Drehmer Rieger, Eraci
Format: article
Publication Date:2020
Country:España
Institution:Universidad Católica de Valencia San Vicente Mártir
Repository:RIUCV. Repositorio de la Universidad Católica de Valencia San Vicente Mártir
Language:English
OAI Identifier:oai:riucv.ucv.es:20.500.12466/3214
Online Access:http://hdl.handle.net/20.500.12466/3214
Access Level:Open access
Keyword:Amyotrophic lateral sclerosis
Neurodegenerative diseases
Oxidative stress
Mitochondrial dysfunction
Nicotinamide riboside
Pterostilbene
3207.11 Neuropatología
2411.11 Neurofisiología
Description
Summary:Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that produces a selective loss of the motor neurons of the spinal cord, brain stem and motor cortex. Oxidative stress (OS) associated with mitochondrial dysfunction and the deterioration of the electron transport chain has been shown to be a factor that contributes to neurodegeneration and plays a potential role in the pathogenesis of ALS. The regions of the central nervous system affected have high levels of reactive oxygen species (ROS) and reduced antioxidant defenses. Scientific studies propose treatment with antioxidants to combat the characteristic OS and the regeneration of nicotinamide adenine dinucleotide (NAD+) levels by the use of precursors. This review examines the possible roles of nicotinamide riboside and pterostilbene as therapeutic strategies in ALS.